Commentary Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/rehabilitation.1.004
Motor Imagery in Facial Palsy Rehabilitation
Teresa Paolucci1,*
- 1Unit of Physical Medicine and Rehabilitation, G. D’ Annunzio University of Chieti-Pescara, Department of Oral Medical Science and Biotechnology (DSMOB), Italy
Corresponding Author
Teresa Paolucci, teresapaolucci@hotmail.com
Received Date: August 28, 2019
Accepted Date: September 16, 2019
Paolucci T. Motor Imagery in Facial Palsy Rehabilitation. J Phys Med Rehabil. 2019; 1(1):13-14.
Copyright: © 2019 Paolucci T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Rehabilitation Providers’ Experiences with Rapid Telerehabilitation Implementation During the COVID-19 Pandemic in the United States
Telehealth has been around since the 1960s as a healthcare delivery modality, though it did not gain widespread acceptance as a viable and reliable clinical tool until the late 1990s, when digital imaging and high speed, high bandwidth telecommunications technology became widely available [1]. Historical boundaries to its acceptance and
Virtual Reality in Chronic Pain Rehabilitation: A Systematic Review
Approximately 19% of adults complain of chronic pain, which poses considerable physical, mental, and economic burdens. Conventional chronic pain management includes physical therapy, analgesic drugs, and the avoidance of pain triggers. Metaverse-related technologies such as virtual reality (VR) are promising complementary approaches. This review aimed to systematically analyse the applications of VR in chronic pain management in the context of rehabilitation.
Preclinical Protective Activity of Lutein on Diclofenac-induced Hepatotoxicity
Diclofenac (DF), a non-steroidal anti-inflammatory drug, may cause hepatotoxicity. Lutein (LT), a naturally occurring compound, has potential therapeutic activities. The protective activity of LT against DF-induced hepatotoxicity in adult Wistar rats was evaluated in this study.
Gabapentin for Ocular Surface Disorders: Bridging Molecular Mechanisms to Therapeutic Innovation
This commentary critically evaluates Rusciano's (2024) comprehensive review on gabapentin (GBP) as a multifaceted therapy for ocular surface diseases, emphasizing its transition from systemic to topical applications. We highlight the review's synthesis of GBP's polypharmacology—spanning calcium channel modulation, anti-inflammatory effects, and neuroprotection—and its innovative integration with nanotechnology (e.g., nanoceria platforms) to overcome corneal delivery challenges while potentially reducing systemic side effects associated with oral administration.
Adherent Natural Killer Cells De Novo Express IL-2Rα and Sustain Long-Lasting, Potent Anti-Tumor Activity in Picomolar Concentrations of IL-2
Natural killer (NK) cells are innate lymphoid cells (ILCs) that play key roles in immunosurveillance and immunoregulation. They constitute a heterogeneous population comprising three principal subpopulations: NK1 (cytotoxic), NK2 (regulatory), and NK3 (adaptive). In response to interleukin-2 (IL-2) stimulation, NK3 cells differentiate into adherent NK (A-NK) cells, which exhibit potent anti-tumor activity. Human A-NK cells are generated by priming and adherence-based selection of peripheral blood NK3 cells in nanomolar (nM) IL-2 concentrations, followed by prolonged restimulation and culture in the same IL-2 conditions.